%0 Journal Article %T 胃食管反流病的药物及内镜治疗的现状
The Current Status of Pharmacological and Endoscopic Treatments for Gastroesophageal Reflux Disease %A 袁希惠 %A 任金凤 %A 杨正英 %A 杨敏媛 %A 刘天宇 %J Advances in Clinical Medicine %P 2468-2476 %@ 2161-8720 %D 2025 %I Hans Publishing %R 10.12677/acm.2025.153883 %X 胃食管反流病(Gastroesophageal Reflux Disease, GERD)是一种常见的消化系统疾病,其治疗包括药物和内镜治疗。质子泵抑制剂(Proton Pump Inhibitors, PPIs)仍是主要药物,钾–氢泵抑制剂(Potassium-Competitive Acid Blockers, P-CABs)等新型药物逐步应用。内镜治疗技术不断发展,为药物难治性GERD提供了新选择。本文综述GERD的药物及内镜治疗的现状,分析其疗效、局限性,并展望未来发展方向,以期为临床治疗提供参考。
Gastroesophageal Reflux Disease (GERD) is a common digestive disorder, with treatment strategies including pharmacological and endoscopic therapies. Proton Pump Inhibitors (PPIs) are still the main drugs, while novel agents such as Potassium-Competitive Acid Blockers (P-CABs) are increasingly utilized. Advances in endoscopic techniques offer new therapeutic options for drug-refractory GERD. This review summarizes the current status of pharmacological and endoscopic treatments for GERD, discusses their efficacy and limitations, and explores future perspectives to provide a reference for clinical treatment. %K 胃食管反流病, %K 药物治疗, %K 内镜治疗, %K 综述
Gastroesophageal Reflux Disease %K Pharmacological Treatment %K Endoscopic Treatment %K Review %U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=110270